Cleared Special

K093882 - SORIN C5 SYSTEM MODEL 58-00-00

K093882 is an FDA 510(k) clearance for SORIN C5 SYSTEM MODEL 58-00-00, manufactured by Sorin Group Deutschland GmbH. The device is a Class 2 Cardiovascular device with product code DTQ cleared through the Special 510(k) pathway after a 28-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2010
Decision
28d
Days
Class 2
Risk

K093882 is an FDA 510(k) clearance for the SORIN C5 SYSTEM MODEL 58-00-00. Classified as Console, Heart-lung Machine, Cardiopulmonary Bypass (product code DTQ), Class II - Special Controls.

Submitted by Sorin Group Deutschland GmbH (North Attleboro, US). The FDA issued a Cleared decision on January 15, 2010 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4220 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Sorin Group Deutschland GmbH devices

FDA 510(k) Submission Details - K093882

510(k) Number K093882 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 18, 2009
Decision Date January 15, 2010
Days to Decision 28 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
97d faster than avg
Panel avg: 125d · This submission: 28d
Pathway characteristics
Modification to existing cleared device.

DTQ Device Classification - Class 2, Special Controls

Product Code DTQ Console, Heart-lung Machine, Cardiopulmonary Bypass
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DTQ Console, Heart-lung Machine, Cardiopulmonary Bypass

All 34
Devices cleared under the same product code (DTQ) and FDA review panel - the closest regulatory comparables to K093882.
ADVANCED PERFUSION SYSTEM 1
K131041 · Terumo Cardiovascular Systems Corp. · Feb 2014
CARDIOHELP SYSTEM
K102726 · Maquet Cardiopulmonary, AG · Apr 2011
SORIN C5 SYSTEM
K103762 · Sorin Group Deutschland GmbH · Jan 2011
SORIN B-CARE5 FOR THE STOCKERT S5 SYSTEM
K092463 · Sorin Group Deutschland GmbH · Nov 2009
AIR PURGE CONTROL SYSTEM FOR S5 SYSTEM MODEL 23-45-05
K091007 · Sorin Group Deutschland GmbH · Jul 2009
STOCKERT S5 SYSTEM, STOCKERT GAS BLENDER
K080832 · Sorin Group Deutschland GmbH · Jul 2008